Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1015444

Serum leptin level in breast cancer


Koprivčić, Ivan; Marjanović, Ksenija; Matić, Anita; Tolušić Levak, Maja; Lovrić, Ivan; Pauzar, Biljana; Erić, Ivan; Wertheimer, Vjekoslav
Serum leptin level in breast cancer // Acta clinica Croatica (2019) (znanstveni, prihvaćen)


CROSBI ID: 1015444 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Serum leptin level in breast cancer

Autori
Koprivčić, Ivan ; Marjanović, Ksenija ; Matić, Anita ; Tolušić Levak, Maja ; Lovrić, Ivan ; Pauzar, Biljana ; Erić, Ivan ; Wertheimer, Vjekoslav

Vrsta, podvrsta
Radovi u časopisima, znanstveni

Izvornik
Acta clinica Croatica (2019)

Status rada
Prihvaćen

Ključne riječi
breast cancer ; leptin ; malignant tumor ; menopause ; obesity

Sažetak
INTRODUCTION: Leptin is a polypeptide which is mostly produced in white fat tissue and important proinflammatory, proangiogenic, proinvasive and mitotic factor. There is more and more evidence that suggest the key role of leptin in breast cancer formation. METHODS: Our study investigated serum leptin levels in patients with benign breast tumors as well as in various breast cancer fenotypes taking into account leptin levels connected to menopausal status and body mass index (BMI). The study included 97 patients which had their breast tumor surgically removed. Serum leptin level for each individual patient was determined by ELISA method. RESULTS: Significantly more women, regardless of whether they have malignant or benign tumors, were in postmenopause and thay have significantly highest level of leptin compared to premenopausal group. The highest level of leptin was in postmenopausal obese women group, compared to other women in postmenopause but also compared to premenopausal women. According only to BMI, females that were obese have significantly higher level of leptin, regardless of the type of tumor. The most significant differences in leptin levels, observed through BMI, are in luminal B1 group. CONCLUSION: Serum leptin level showed to be a good diagnostic parameter which speaks in favor of higher possibility of formation of breast cancer.

Izvorni jezik
Engleski



POVEZANOST RADA


Ustanove:
Fakultet za dentalnu medicinu i zdravstvo, Osijek


Citiraj ovu publikaciju

Koprivčić, Ivan; Marjanović, Ksenija; Matić, Anita; Tolušić Levak, Maja; Lovrić, Ivan; Pauzar, Biljana; Erić, Ivan; Wertheimer, Vjekoslav
Serum leptin level in breast cancer // Acta clinica Croatica (2019) (znanstveni, prihvaćen)
Koprivčić, I., Marjanović, K., Matić, A., Tolušić Levak, M., Lovrić, I., Pauzar, B., Erić, I. & Wertheimer, V. (2019) Serum leptin level in breast cancer. Prihvaćen za objavljivanje u Acta clinica Croatica. [Preprint].
@unknown{unknown, year = {2019}, keywords = {breast cancer, leptin, malignant tumor, menopause, obesity}, journal = {Acta clinica Croatica}, title = {Serum leptin level in breast cancer}, keyword = {breast cancer, leptin, malignant tumor, menopause, obesity} }
@unknown{unknown, year = {2019}, keywords = {breast cancer, leptin, malignant tumor, menopause, obesity}, journal = {Acta clinica Croatica}, title = {Serum leptin level in breast cancer}, keyword = {breast cancer, leptin, malignant tumor, menopause, obesity} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font